Summary Of Loading Off Bottom - As At Close December 17.

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
147
Summary Of Loading Off Bottom - As At Close December 17.

Bought at .4000:

Aug 29: 400

Bought at .3500:

Aug 29: 100

Bought at .3000 / .3200 / .3275

Aug 28: 42,000
Oct 24: 2,599
Oct 26: 7,635
Oct 29: 4,915
Oct 30: 900

Total: 58,049

Bought at .2500 / .2553 / .2600 / .2779 / .2788 / .2800 / .2843 / .2887 / .2888 / .2998 / .2999

Sep 24: 45,374
Sep 15: 124
Oct 2: 990
Oct 18: 26,616
Oct 19: 25,000
Oct 22: 11,500
Oct 23: 10,000
Oct 24: 10,000

Total: 129,604

Bought at .2100 / .2194 / .2300 / .2325 / .2350 / .2400 / .2469:

Aug 29: 200
Sep 24: 5,194
Sep 27: 2,425
Oct 1: 10,000
Oct 12: 155
Oct 22: 520
Oct 26: 8
Oct 30: 30
Nov 5: 1
Nov 8: 3,469
Nov 9: 800
Nov 27: 5,150
Dec 4: 400
Dec 14: 1,490

Total: 29,842

Bought at .2000:

Aug 28: 63,000
Sep 21: 6,499
Sep 25: 10
Sep 26: 2,500

Total: 72,009

Bought at .1600 / .1650 / .1670 / .1700 / .1800 / .1900 / .1940:

Aug 31: 800
Sep 21: 2,683
Oct 2: 200
Oct 8: 10,000
Oct 15: 613
Oct 16: 5,187
Oct 17: 2,500
Nov 8: 9,100
Nov 9: 1,300
Nov 12: 10,130
Nov 13: 10,000
Nov 14: 8,008

Total: 60,421

Bought at .1500 / .1501 / .1510 / .1525 /.1530 / .1550:

Aug 31: 1,990
Sep 21: 14,154
Oct 10: 413
Oct 11: 300
Oct 12: 200
Oct 15: 9,387
Nov 16: 1
Nov 19: 66
Nov 27: 150

Total: 26,661

Bought at .1425 / .1450 / .1475:

Sep 13: 1,541
Sep 14: 580
Sep 18. 20,000

Total: 22,121

Bought at .1400:

Aug 31: 6,800
Sep 5: 100
Sep 12: 19,900

Total: 26,800

Bought at .1300 / .1350:

Aug 31: 9,900

Bought at .1200 / .1250 / .12555 / .1270:

Aug 30: 8,000
Aug 31: 999
Sep 17: 5,100
Sep 18: 6,200
Sep 20: 1,260
Nov 30: 75
Dec 3: 50
Dec 6: 9
Dec 10: 1
Dec 17: 1

Total: 21,695

Bought at .1100

Sep 5: 5,000

Bought at .1000:

Aug 28: 245,000
Aug 31: 55,512
Sep 4: 9,905
Sep 12: 5,000

Total: 315,417

Bought at .0900:

Sep 12: 995

Bought at .8000 / .0850:

Sep 10: 3,370
Sep 11: 3,099

Total: 3,470

Bought at .0701:

Sep 5: 26
Sep 6: 2,917
Sep 7: 4,926
Sep 10: 6,390

Total: 14,259

Notes:
Nobody had .1s (.0001s) previously.
Very few had .2 (.0002s) previously - only 5M from 2018 prior to Aug 28.







American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 12

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 5

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 12

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 9

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 11

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 7

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading